Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 1 blog post.

Can Immunotherapy Succeed in Glioblastoma?

Cancer Currents: An NCI Cancer Research Blog, 24 May 2018

Despite continued efforts to develop new therapies for glioblastoma, none have been able to improve how long patients live…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.